DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Dexone 4 is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in DEXONE 4 is dexamethasone. There are thirty-nine drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
A generic version of DEXONE 4 was approved as dexamethasone by XSPIRE PHARMA on April 28th, 1983.
Recent Clinical Trials for DEXONE 4
Identify potential brand extensions & 505(b)(2) entrants
|Southwest Oncology Group||Phase 2|
|Janssen Pharmaceuticals||Phase 2|
|University of California, San Francisco||Phase 2|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Solvay||DEXONE 4||dexamethasone||TABLET;ORAL||084992-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|